UNSPSC 51152043: Promoxolane

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51152043

Definition

This classification denotes a muscle relaxant with the molecular formula C10H20O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JHI9RRY52E, chemically known as 2,2-diisopropyl-4-methanol-1,3-dioxolane but generally known as promoxolane, which bears US NIH Compound Identifier 10105. European Medicines Agency schedules Promoxolane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10091MIG.

Read the full definition

The term PROMOXOLANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). PROMOXOLANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promoxolane under HS 29329970 and SITC 51569. As of Q4 2014, PROMOXOLANE remains the US FDA Preferred Term for this commodity. Promoxolane bears US NLM identifiers UMLS ID C0520813 and NCI Concept Code C82296. SMILES: CC(C)C1(OCC(O1)CO)C(C)C.

About UNSPSC 51152043

UNSPSC 51152043 Promoxolane is a Commodity code for a pharmaceutical product, though the recent state and local activity tagged under it concerns naloxone and drug deactivation systems procurement rather than promoxolane itself. Seminole County, Florida issued an IFB in mid-2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building. The procurement requires vendors to submit bids electronically through the county's e-Procurement Portal, include all shipping and delivery costs in pricing, maintain specified insurance coverages (workers' compensation, commercial general liability, and professional liability), comply with drug-free workplace certification and E-Verify requirements, and accept a three-month probationary period during which the county may terminate the agreement with or without cause. The contract carries a two-year initial term with a one-year renewal option and is potentially funded through FEMA, introducing compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

The code shows limited recent activity, with a single documented opportunity from a county health department in Florida. The mismatch between the code's nominal scope (promoxolane, a pharmaceutical compound) and the actual procurement (naloxone and drug deactivation equipment) suggests either a classification error in the county's tagging or a significant divergence between the code's intent and current state and local buying patterns. Response deadlines for the Seminole County IFB have passed (final deadline was July 26, 2023, with questions due July 21, 2023), making this opportunity closed. No other recent state or local solicitations under this code are documented in the available records.

Quick answers

What is UNSPSC 51152043?

UNSPSC 51152043 is Promoxolane, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51152043?

UNSPSC 51152043 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51152043

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code